Exact Mass: 457.327745
Exact Mass Matches: 457.327745
Found 35 metabolites which its exact mass value is equals to given mass value 457.327745
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
O‐[(4Z)‐Decenoyl]carnitine
O‚Äê[(4Z)‚Äêdecenoyl]carnitine is an acylcarnitine. More specifically, it is an 3-[(4Z)-dec-4-enoyloxy]-4-(trimethylazaniumyl)butanoate ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. O‚Äê[(4Z)‚Äêdecenoyl]carnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine O‚Äê[(4Z)‚Äêdecenoyl]carnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular O‚Äê[(4Z)‚Äêdecenoyl]carnitine is elevated in the blood or plasma of individuals with overweight (PMID: 30322392). It is also decreased in the blood or plasma of individuals with schizophrenia (PMID: 31161852) and familial mediterranean fever (PMID: 29900937). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
Ile Lys Val Val
C22H43N5O5 (457.32640280000004)
Ile Val Lys Val
C22H43N5O5 (457.32640280000004)
Ile Val Val Lys
C22H43N5O5 (457.32640280000004)
Lys Ile Val Val
C22H43N5O5 (457.32640280000004)
Lys Leu Val Val
C22H43N5O5 (457.32640280000004)
Lys Val Ile Val
C22H43N5O5 (457.32640280000004)
Lys Val Leu Val
C22H43N5O5 (457.32640280000004)
Lys Val Val Ile
C22H43N5O5 (457.32640280000004)
Lys Val Val Leu
C22H43N5O5 (457.32640280000004)
Leu Lys Val Val
C22H43N5O5 (457.32640280000004)
Leu Val Lys Val
C22H43N5O5 (457.32640280000004)
Leu Val Val Lys
C22H43N5O5 (457.32640280000004)
Val Ile Lys Val
C22H43N5O5 (457.32640280000004)
Val Ile Val Lys
C22H43N5O5 (457.32640280000004)
Val Lys Ile Val
C22H43N5O5 (457.32640280000004)
Val Lys Leu Val
C22H43N5O5 (457.32640280000004)
Val Lys Val Ile
C22H43N5O5 (457.32640280000004)
Val Lys Val Leu
C22H43N5O5 (457.32640280000004)
Val Leu Lys Val
C22H43N5O5 (457.32640280000004)
Val Leu Val Lys
C22H43N5O5 (457.32640280000004)
Val Val Ile Lys
C22H43N5O5 (457.32640280000004)
Val Val Lys Ile
C22H43N5O5 (457.32640280000004)
Val Val Lys Leu
C22H43N5O5 (457.32640280000004)
Val Val Leu Lys
C22H43N5O5 (457.32640280000004)
3-[3-[(E)-dec-4-enoyl]oxy-4-(trimethylazaniumyl)butanoyl]oxy-4-(trimethylazaniumyl)butanoate
(1r,2s,6s,9s,10s,11r,12s,14s,15s,20s,23r,24s)-10,12-dihydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacos-17-en-20-yl formate
C28H43NO4 (457.31919180000006)
2-(10-hydroxy-3,5,7,9,11,13-hexamethyltetradeca-2,5,7,11-tetraen-1-yl)-5,6-dimethoxy-3-methylpyridin-4-ol
C28H43NO4 (457.31919180000006)
2,3-dimethoxy-6-(10-methoxy-3,7,9,11,13-pentamethyltetradeca-2,5,7,11-tetraen-1-yl)-5-methylpyridin-4-ol
C28H43NO4 (457.31919180000006)
2,3-dimethoxy-6-[(2e,5e,7e,9s,10s,11e)-10-methoxy-3,7,9,11,13-pentamethyltetradeca-2,5,7,11-tetraen-1-yl]-5-methylpyridin-4-ol
C28H43NO4 (457.31919180000006)
2-[(2e,5e,7e,9s,10r,11e)-10-hydroxy-3,5,7,9,11,13-hexamethyltetradeca-2,5,7,11-tetraen-1-yl]-5,6-dimethoxy-3-methylpyridin-4-ol
C28H43NO4 (457.31919180000006)